摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-(4-fluorophenyl)-3-oxo-2-(pyrimidin-4-yl)propanenitrile

中文名称
——
中文别名
——
英文名称
3-(4-fluorophenyl)-3-oxo-2-(pyrimidin-4-yl)propanenitrile
英文别名
3-(4-Fluorophenyl)-3-oxo-2-pyrimidin-4-ylpropanenitrile
3-(4-fluorophenyl)-3-oxo-2-(pyrimidin-4-yl)propanenitrile化学式
CAS
——
化学式
C13H8FN3O
mdl
——
分子量
241.224
InChiKey
TYRBNVFSCNKPSJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    66.6
  • 氢给体数:
    0
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-(4-fluorophenyl)-3-oxo-2-(pyrimidin-4-yl)propanenitrileN,N-二甲基甲酰胺三氯氧磷 作用下, 以 乙腈 为溶剂, 反应 2.0h, 生成
    参考文献:
    名称:
    An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl)isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor
    摘要:
    5-Acylamino-4-(4-pyrimidinyl)isoxazole derivative AKP-001 is a p38 mitogen-activated protein kinase inhibitor previously developed in our laboratory as an anti-inflammatory agent. Herein, we report our studies leading to the development of an improved synthetic route to AKP-001, which shows several advantages compared to the previously reported laboratory-scale process, namely, a lower number of steps, superior chemical yield and atom efficiency, and applicability at an industrial scale.
    DOI:
    10.3987/com-17-13700
  • 作为产物:
    描述:
    4-甲基嘧啶盐酸羟胺 、 sodium amide 、 六甲基二硅氮烷 、 sodium hydroxide 作用下, 以 甲醇二乙二醇二甲醚N,N-二甲基甲酰胺 为溶剂, 反应 5.0h, 生成 3-(4-fluorophenyl)-3-oxo-2-(pyrimidin-4-yl)propanenitrile
    参考文献:
    名称:
    An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl)isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor
    摘要:
    5-Acylamino-4-(4-pyrimidinyl)isoxazole derivative AKP-001 is a p38 mitogen-activated protein kinase inhibitor previously developed in our laboratory as an anti-inflammatory agent. Herein, we report our studies leading to the development of an improved synthetic route to AKP-001, which shows several advantages compared to the previously reported laboratory-scale process, namely, a lower number of steps, superior chemical yield and atom efficiency, and applicability at an industrial scale.
    DOI:
    10.3987/com-17-13700
点击查看最新优质反应信息

文献信息

  • Condensed pyrazole derivatives with interleukin-1 and tumour necrosis factor inhibitory activity
    申请人:FUJISAWA PHARMACEUTICAL CO., LTD.
    公开号:EP0531901A2
    公开(公告)日:1993-03-17
    1. A compound of the formula : wherein R¹ isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), R² isaryl which may have suitable substituent(s) or heterocyclic group which may have suitable substituent(s), and Y isa bivalent radical selected from (in which ---- means single bond or double bond), each of which may have suitable substituent(s), and pharmaceutically acceptable salts thereof, processes for their preparation and pharmaceutical compositions comprising them.
    1.式中的化合物: 式中 R¹为芳基,可具有合适的取代基,或为杂环基,可具有合适的取代基、 R² 是芳基,可带有合适的取代基或杂环基,可带有合适的取代基,以及 Y 是二价基,选自 (其中 ---- 指单键或双键),其中每个基团可具有合适的取代基,以及 它们的药学上可接受的盐、其制备工艺和包含它们的药物组合物。
  • US5356897A
    申请人:——
    公开号:US5356897A
    公开(公告)日:1994-10-18
  • US5478827A
    申请人:——
    公开号:US5478827A
    公开(公告)日:1995-12-26
  • US5624931A
    申请人:——
    公开号:US5624931A
    公开(公告)日:1997-04-29
  • An Efficient and Practical Method for the Synthesis of the 5-Acylamino-4-(4-pyrimidinyl)isoxazole Derivative AKP-001, a Potent P38 MAP Kinase Inhibitor
    作者:Shuji Ohta、Takahisa Saito、Jun-ya Kato、Shuichiro Sato、Hiroyuki Hayashi、Koichi Hasumi
    DOI:10.3987/com-17-13700
    日期:——
    5-Acylamino-4-(4-pyrimidinyl)isoxazole derivative AKP-001 is a p38 mitogen-activated protein kinase inhibitor previously developed in our laboratory as an anti-inflammatory agent. Herein, we report our studies leading to the development of an improved synthetic route to AKP-001, which shows several advantages compared to the previously reported laboratory-scale process, namely, a lower number of steps, superior chemical yield and atom efficiency, and applicability at an industrial scale.
查看更多